Human Papilomma Virus (HPV) is a kind of illness which commonly sexually transmitted to the genital area. In the United States alone, it is estimated that more than 6,000,000 people are infected with this illness each year. The amount or people who are infected are increased and threatening many other through sexual intercourse.

Regarding the increasing amount of people transmitted with Human Papilomma Virus (HPV) which account for 70% of cervical cancer in US, the US Food and Drug Administration (FDA) has approved the DNA test on this Cervical Cancer Virus. The test identifies the two Human Papilomma Virus (HPV) types 16 and 18 in cervix cells. The test it self called Cervista HPV 16/18 and will be helpful for health care professionals to fin a better way identifying woman who has higher risk of developing cervical; cancer.

Hopefully, with the approval from FDA in this test, the healthcare professional can handle the signs of pervical cancer on women and prevent t from getting worse or heal it as soon as possible. The second DNA test which will detect all of the high risk HPV strains is called Cevista HPV HR test. Those two tests will bring new hope for American people to find the way out of the cervical cancer menace.